- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 582526, 9 pages
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells
1Stem Cell and Tissue Engineering Department, Research Center for Science and Technology in Medicine (RCSTiM), Tehran University of Medical Sciences, Tehran, Iran
2Faculty of Medicine, Islamic Azad University, Mashhad Branch, Mashhad 19988-96953, Iran
3Medical Nanotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
4Rajaei Cardiovascular, Medical, and Research Centre, Iran University of Medical Sciences, P.O. Box 14185-615, Tehran, Iran
Received 10 April 2013; Revised 15 July 2013; Accepted 15 July 2013
Academic Editor: Paul Higgins
Copyright © 2013 Anahita Rahmani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. Noureddini, J. Verdi, S. A. Mortazavi Tabatabaei, S. Sharif, and A. Shoae Hassani, “Human endometrial stem cell neurogenesis in response to NGF and bFGF,” Cell Biology International, vol. 36, no. 1, pp. 961–966, 2012.
- A. Shoae-Hassani, S. A. Mortazavi-Tabatabaei, S. Sharif, H. Rezaei-Khaligh, and J. Verdi, “DHEA provides a microenvironment for endometrial stem cells neurogenesis,” Medical Hypotheses, vol. 76, no. 6, pp. 843–846, 2011.
- H. A. Cameron, “Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus,” Neuroscience, vol. 61, no. 2, pp. 203–209, 1994.
- P.-M. Lledo, M. Alonso, and M. S. Grubb, “Adult neurogenesis and functional plasticity in neuronal circuits,” Nature Reviews Neuroscience, vol. 7, no. 3, pp. 179–193, 2006.
- R. Ranganathan, E. R. Sawin, C. Trent, and H. R. Horvitz, “Mutations in the Caenorhabditis elegansserotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine,” Journal of Neuroscience, vol. 21, no. 16, pp. 5871–5884, 2001.
- A. Abdipranoto, S. Wu, S. Stayte, and B. Vissel, “The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development,” CNS and Neurological Disorders-Drug Targets, vol. 7, no. 2, pp. 187–210, 2008.
- H. Dudek, S. R. Datta, T. F. Franke et al., “Regulation of neuronal survival by the serine-threonine protein kinase Akt,” Science, vol. 275, no. 5300, pp. 661–665, 1997.
- S. G. Kennedy, E. S. Kandel, T. K. Cross, and N. Hay, “Akt/protein kinase B inhibits cell death by preventing the release of cytochrome C from mitochondria,” Molecular and Cellular Biology, vol. 19, no. 8, pp. 5800–5810, 1999.
- A. Brunet, S. R. Datta, and M. E. Greenberg, “Transcription-dependent and—independent control of neuronal survival by the PI3K-Akt signaling pathway,” Current Opinion in Neurobiology, vol. 11, no. 3, pp. 297–305, 2001.
- T. F. Franke, C. P. Hornik, L. Segev, G. A. Shostak, and C. Sugimoto, “PI3K/Akt and apoptosis: size matters,” Oncogene, vol. 22, no. 56, pp. 8983–8998, 2003.
- A. Shoae-Hassani, A. M. Seifalian, S. A. Mortazavi-Tabatabaei, S. Sharif, A. Azimi, and J. Verdi, “Differentiation of human endometrial stem cells into urothelial cells on a three-dimensional nanofibrous silk-collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall,” Journal of Tissue Engineering and Regenerative Medicine, 2013.
- C. E. Gargett, “Uterine stem cells: what is the evidence?” Human Reproduction Update, vol. 13, no. 1, pp. 87–101, 2007.
- A. Shoae-Hassani, S. A. Mortazavi-Tabatabaei, S. Sharif, S. Madadi, H. Rezaei-Khaligh, and J. Verdi, “Recombinant lambda bacteriophage displaying nanobody towards third domain of Her-II epitope inhibits proliferation of breast carcinoma SKBR-3 cell line,” Archivum Immunologiae et Therapiae Experimentalis, vol. 61, no. 1, pp. 75–83, 2013.
- F. Karege, M. Schwald, and M. Cisse, “Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets,” Neuroscience Letters, vol. 328, no. 3, pp. 261–264, 2002.
- G. Mercier, A. M. Lennon, B. Renouf et al., “MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes,” Journal of Molecular Neuroscience, vol. 24, no. 2, pp. 207–216, 2004.
- F. Fumagalli, R. Molteni, F. Calabrese, A. Frasca, G. Racagni, and M. A. Riva, “Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain,” Journal of Neurochemistry, vol. 93, no. 6, pp. 1551–1560, 2005.
- E. Ha, K. H. Jung, B.-K. Choe et al., “Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells,” Neuroscience Letters, vol. 397, no. 3, pp. 185–189, 2006.
- R. K. Choy and J. H. Thomas, “Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins,” Molecular Cell, vol. 4, no. 2, pp. 143–152, 1999.
- C.-T. Lee, J. Chen, T. Hayashi et al., “A mechanism for the inhibition of neural progenitor cell proliferation by cocaine,” PLoS Medicine, vol. 5, no. 6, article e117, 2008.
- W. J. Ray, G. Bain, M. Yao, and D. I. Gottlieb, “CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family,” Journal of Biological Chemistry, vol. 272, no. 30, pp. 18702–18708, 1997.
- D. Weinshenker, G. Garriga, and J. H. Thomas, “Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans,” Journal of Neuroscience, vol. 15, no. 10, pp. 6975–6985, 1995.
- G. Schaarschmidt, F. Wegner, S. C. Schwarz, H. Schmidt, and J. Schwarz, “Characterization of voltage-gated potassium channels in human neural progenitor cells,” PLoS ONE, vol. 4, no. 7, Article ID e6168, 2009.
- R. M. W. de Oliveira, S. Martin, C. L. de Oliveira et al., “Eag1, Eag2, and SK3 potassium channel expression in the rat hippocampus after global transient brain ischemia,” Journal of Neuroscience Research, vol. 90, no. 3, pp. 632–640, 2012.
- M. S. Cho, Y.-E. Lee, J. Y. Kim et al., “Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 9, pp. 3392–3397, 2008.
- Y.-H. Rhee, J.-Y. Ko, M.-Y. Chang et al., “Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease,” Journal of Clinical Investigation, vol. 121, no. 6, pp. 2326–2335, 2011.
- A. Shoae-Hassani, S. Sharif, and J. Verdi, “The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming,” Cell Biology International, vol. 35, no. 1, pp. 1037–1041, 2011.
- D. S. Kwon, C. H. Kwon, J. H. Kim, J. S. Woo, J. S. Jung, and Y. K. Kim, “Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells,” European Journal of Cell Biology, vol. 85, no. 11, pp. 1189–1199, 2006.
- J. W. Kim, J. E. Lee, M. J. Kim, E.-G. Cho, S.-G. Cho, and E.-J. Choi, “Glycogen synthase kinase 3β is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1),” Journal of Biological Chemistry, vol. 278, no. 16, pp. 13995–14001, 2003.
- K. Frebel and S. Wiese, “Signalling molecules essential for neuronal survival and differentiation,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1287–1290, 2006.
- H. E. Scharfman and R. Hen, “Is more neurogenesis always better?” Science, vol. 315, no. 5810, pp. 336–338, 2007.
- A. J. Rush, M. H. Trivedi, S. R. Wisniewski et al., “Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report,” American Journal of Psychiatry, vol. 163, no. 11, pp. 1905–1917, 2006.